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pen accessAbstract There is much debate regarding the amount of perioperative ﬂuid administration in rela-
tion to patient outcome.
Fluid shifting towards the interstitial space is of two types (physiologic and pathologic) across the
vascular endothelial membrane. This membrane, of 1 lm thickness, is formed of an endothelial
layer coated by glycocalyx, a small concentration of albumin, and a non-circulating part of plasma.
It acts as a gateway to the interstitial space with a primary molecular ﬁller function, generating an
effective molecular ﬁlter function, generating an effective molecular gradient across its thickness.
Since the early sixties, perioperative ﬂuid requirements were calculated by considering pre-existing
deﬁcits, maintenance volumes, and third-spaces loss, depending on the type of surgery. Based on
this, a goal-directed ‘‘liberal’’ ﬂuid approach was modulated. On the other hand, a ‘‘restrictive’’
ﬂuid approach was later suggested to achieve better patient outcome. Extremes of either approach
were shown to induce hyper- or hypovolemia, respectively. However, there are no clear deﬁnitions
to describe the volume status of patients.
The literature is currently characterized by inconsistency and contradiction regarding patient
outcome parallel to perioperative ‘‘too much’’ or ‘‘too little’’ ﬂuid administration. There is no
single ﬂuid regimen which provides optimal ﬂuid volumes to all surgical patients all the times.om
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314 M.E. MoemenSo, available literature is discussed in this article with an early evidence of a preferred ‘‘adequate’’
rather than a ‘‘liberal’’ or a ‘‘restrictive’’ ﬂuid approach.
Further systematic reviews of randomized controlled trials are recommended to predict the volumes
and types of administered ﬂuids, and its timing as important determinants of postoperative patient
outcome. Special evidence is also needed for ‘‘liberal’’ versus ‘‘restrictive’’ hemoglobin therapy to
determine the same goals.
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There is much debate regarding the amount of perioperative
ﬂuid administration in relation to patient outcome.
Regarding healthy individuals, perioperative ﬂuid require-
ments are well-established for different age groups, as avoiding
excessive ﬂuid loss or administration provides successful
homeostasis [1].
Regarding critically-ill patients, perioperative ﬂuid therapy
is complex, as there may be much ﬂuid deﬁcits with impaired
capacity to maintain homeostasis. Some complicating factors
include comorbidities, systemic inﬂammation, increased anti-
diuretic hormone liberation, together with disturbances in
the rennin-angiotensin system, and the atrial natriuretic pep-
tide. So, the perioperative outcome of critically-ill patients
may be linked with the volumes of perioperative ﬂuid admin-
istration [2,3].
The intravascular ﬂuid compartment in the normal adult
comprises two-thirds of total body water. The remaining
one-third designates the extracellular compartment, consisting
of plasma and interstitial ﬂuid, where water and small solutes
can easily exchange for cell nutrition. This physiological distri-
bution of ﬂuids is maintained by biological membrane barriers
and oxygen – consuming ion pumps.
According to Ernest Starling [4], the hydrostatic pressure in
blood vessels is high, as is the colloid osmotic pressure. The
interstitial ﬂuid contains low amounts of protein with low
hydrostatic pressure. A small net amount of ﬂuid and protein
shifts out of the blood vessels all the time, and returns to the
intravascular space by the lymph vessels.
The relation between the interstitial space and the so-called
third-space needs to be clariﬁed. The third-space is divided into
two components; anatomical and non-anatomical. The ana-
tomical component represents the functional interstitial space,
allowing physiologic ﬂuid shifting across the intact vascularbarriers. As long as it is quantitatively managed by the lymph
system, a physiologic shift does not cause interstitial edema [5].
The non-anatomical component is a non-functional one, sepa-
rated from the interstitial space. Examples are the peritoneal
cavity and the traumatized tissues. A non-functional third-
space component does not normally exist [6]. If it pathologi-
cally exists, it is not in equilibrium with the functional compo-
nent, being anatomically separated [7].
Fluid shifting towards the interstitial space is of two types.
Type 1 is a physiologic shifting occurring across a healthy bio-
logical barrier. Type 2 is a pathologic shifting due to lymph
vessels destruction by surgery, or endothelial damage by
inﬂammation, increasing vascular permeability [8].
So, it is mostly the condition of the biological membrane
that counts in the ﬂuid shifting process.
The healthy biological vascular barrier is coated by the endo-
thelial glycocalyx, consisting of proteoglycans and glycopro-
teins. It is considered the natural gateway to the interstitial
space [7]. It is bound with a small concentration of albumin
[9], and 700–1000 ml of plasma ﬁxed within the endothelial sur-
face layer [10], to form a functional thickness of about 1 lm [11].
This non-circulating part of plasma volume is in dynamic equi-
librium with the circulating part. The presence of such a healthy
vascular membrane maintains a barrier to prevent excessive
ﬂuid shifting [9]. It acts as a primary molecular ﬁlter, and gener-
ates an effective oncotic gradient across its thickness [4].
The biological membrane prevents leukocyte and platelet
adhesion, against both inﬂammation and edema formation
[8]. Its destruction allows transcapillary ﬂuid shifting to equal-
ize hydrostatic and oncotic pressures between blood and
tissues leading to a catastrophe [7]. This implies, perioperative-
ly, that the endothelial biological barrier should be preserved
to inhibit a pathological type 2 ﬂuid shifting into the interstitial
space. Diminution of destruction of the membrane can im-
prove its integrity.
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ignores the fact that the intravascular volume expansion is ex-
pected to terminate at the end of surgery, with restoration of
the vascular tone. Relative hypervolemia follows [12], and
the kidney is not of much help in this situation due to its re-
duced excretory capacity [13]. Such hypervolemia may induce
glycocalyx damage [14].
With this background, anesthetists and intensivists must
apply art as well as science to adapt ﬂuid regimens in order
to optimize ﬂuid therapy, because adherence to a ﬁxed regimen
may be a recipe for disaster [15].
2. Fluid administration
According to current knowledge, perioperative ﬂuid adminis-
tration must replace two kinds of ﬂuid loss:
– Positive loss in the form of insensible perspiration and
urine, and a negative deﬁcit due to preoperative fasting.
The preoperative fasted patient is considered hypovolemic
due to these losses [16]. So, preoperative volume loading
is considered mandatory by many [17–20].
– Loss of blood due to trauma and surgery, which should be
replaced by blood and plasma transfusion.
Since the early sixties, ﬂuid management is calculated by
considering pre-existing deﬁcits, maintenance requirements,
and replacement of loss depending on mild, moderate, or ma-
jor surgery. A practice of large amounts of ﬂuid administration
was established to replace third-space loss.
Recently, it is suggested that for management of type 1
physiologic ﬂuid shifting, crystalloids should be used to replace
insensible perspiration and urine loss, while colloids are used
to substitute blood loss [7]. There is no rationale to replace
blood loss with a three- or fourfold volumes of crystalloids.
Nor is there evidence to increase crystalloid infusion rate when
patients are clinically hypovolemic during surgery [7]. For
management of type 2 pathologic shifting, the biological bar-
rier should be protected. To achieve such a goal, atraumatic
surgical techniques with minimal lymph vessels destruction,
neuro-axial anesthetic blockade to reduce the stress response,
and trying to avoid hypervolemia are to be considered.
3. Fluid therapy: too much or too little
Some authors advocate ‘‘liberal’’ or high volume ﬂuid admin-
istration [18,21–24], while others advocate ‘‘restrictive’’ or low
volume ﬂuid administration [17,25,26]. At present, periopera-
tive ‘‘too much’’ versus ‘‘too little’’ ﬂuid administration is an
issue for scientiﬁc evidence.
4. The ‘‘liberal’’ approach
Perioperative ‘‘liberal’’ ﬂuid approach includes ﬂuid preload-
ing before establishment of anesthesia to counteract drug-in-
duced vasodilatation, high intraoperative ﬂuid volumes, with
not uncommon positive ﬂuid balance in the postoperative per-
iod [27].
The ‘‘liberal’’ approach aims to optimize total blood vol-
ume. To assess the volume status of patients, a wide range of
clinical (e.g. capillary reﬁll), physiological (e.g. heart rate, urineoutput), and biochemical (acid–base deﬁcits, lactate levels)
parameters are useful. Commonly used continuous parameters
as circulating and ﬁlling pressures do not correlate with the
volume status [28].
However, blood volume responsiveness, occasionally re-
ferred to as goal-directed approach [7], can be achieved by
stroke volume variations [29], or esophageal Doppler-guided
intravenous ﬂuid boluses [7]. But, it is impossible to apply
the latter to an awake patient [7]. The goal-directed approach,
aiming for supranormal oxygenation, proposes that increased
oxygen delivery (>600 ml/min/m2) targeted by high cardiac
output (>4.5 L/min/m2) is the most signiﬁcant factor in deter-
mining lower morbidity and reduced length of hospital stay
[30]. But, excessive ﬂuid overload was shown to encourage ede-
ma formation, anastomotic leaks, coagulation factors dilution,
and prolonged hospital stay [17], against previous beliefs that
accumulation of ﬂuids in the tissues was harmless [31], and
that hypervolemia induced minor problems [32]. According
to such beliefs, unpredictable ﬂuid shifts towards the third-
space required generous ﬂuid substitution [33].
The global goal-directed haemodynamic ﬂuid approach has
been challenged by a regional splanchnic-directed ﬂuid ap-
proach aiming to normalize the intramucosal pH [34]. We sug-
gested a combined global and regional ﬂuid approach, as both
sides of the coin, for resuscitation in severe sepsis and septic
shock, with satisfactory patient outcomes [35,36].
A study in 1990 concluded that postoperative ﬂuid overload
is not a benign problem. This is because infusion of large
amounts of crystalloids, and if necessary blood products, has
proved to be followed by postoperative weight gain that corre-
lates with mortality. In patients who gained <10% of body
weight, mortality was 10%. In patients who gained 10–20%
of body weight, mortality was 32%. In those who gained
>20% of body weight, mortality was 100% [37]. What is actu-
ally puzzling is that in 2004, an important randomized, double-
blind study including 16 ICU populations in Australia and
New Zealand, compared Saline versus Albumin Fluid Evalua-
tion (SAFE) for resuscitation, but with similar mortality out-
come at 28 days. The study concluded that both saline and
albumin should be considered clinically equivalent treatment
for intravascular volume resuscitation in a heterogenous pa-
tient population in the ICU [38].5. The ‘‘restrictive approach’’
Some authors applied a ‘‘restrictive’’ low volume ﬂuid ap-
proach during the management of their patients [17,24,25].
Fluid restriction was sometimes estimated as 10% less volumes
than the standard [39].
The ‘‘restrictive’’ ﬂuid approach was shown to induce post-
operative hypovolemia and reduced tissue perfusion with or
without shock [17,24,25]. This might be due to depriving pa-
tients from their actual needs of ﬂuids. However, Matol et
al. appraised the ‘‘restrictive’’ approach to reduce postopera-
tive morbidity and hospital stay [40].
On the other hand, a careful comparison of different study
protocols showed that many ‘‘restrictive’’ approaches actually
represented ‘‘adequate’’ ﬂuid ‘‘substitution’’, exhibited by
hemodynamic stability [17]. This might be true because the
extracellular deﬁcit after the usual preoperative fasting proved
to be negligible [41], and the basal ﬂuid loss via insensible peri-
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during major abdominal surgery [42].
It remains to be clear that we are in actual need for evidence-
based guidelines for perioperative ﬂuid administration [43].6. A preliminary evidence of ‘‘adequate’’ approach
Holte et al. [44] compared ‘‘liberal’’ versus ‘‘restrictive’’ Ringer
Lactate administration during laparoscopic cholecystectomy, a
minimally invasive surgery. They found that an intraoperative
‘‘liberal’’ approach of approximately 3 L of Ringer Lactate
(40 ml/kg over 1.5 h starting from induction of anesthesia), sig-
niﬁcantly improved perioperative organ functions and recovery
with shortened hospital stay. They also suggested that an intra-
operative ‘‘restrictive’’ regimen of approximately 1 L of Ringer
Lactate (15 ml/kg over 1.5 h starting from induction of anesthe-
sia), resulted in postoperative functional hypovolemia. In the
same direction, a gynecological laparoscopy study reported de-
creased postoperative nausea and vomiting, when using intraop-
erative ‘‘liberal’’ versus ‘‘restrictive’’RingerLactate regimen [45].
Holte et al. [46] carried out a further study to investigate
whether their previously demonstrated improved patient out-
come after ‘‘liberal’’ ﬂuids during laparoscopic cholecystec-
tomy, could be due to avoidance of postoperative
hypovolemia. A volume kinetic analysis of identical pre- and
postoperative volume loads of Ringer Lactate (12.5 ml/kg),
was the method used to prove the presence or absence of post-
operative hypovolemia. The technique of volume kinetic anal-
ysis offers a method to prove that the body strives to maintain
volume homeostasis of ﬂuid spaces [47]. The model proved
effective for evaluating perioperative ﬂuid shifting, and for dis-
tinguishing normovolemic versus hypovolemic conditions [48].
Using this model, Holte et al. [46] proved the absence of hyp-
ovolemia after intraoperative ‘‘restrictive’’ ﬂuid administra-
tion. They concluded that the differences in functional
outcome between the two ﬂuid regimens could be attributed
to the minimally invasive surgery – per se rather than being
inﬂuenced by the amount of intraoperative ﬂuid administra-
tion. However, as a conclusion of a systematic review of 80
randomized controlled trials (RCTs), Holte and Kehlet [49],
have recommended ‘‘avoiding ﬂuid overloading during major
surgical procedures’’. So, a role of anesthesia and surgery –
per se – was suggested to affect patient outcome [46]. Previous
studies found signiﬁcantly decreased clearance of infused crys-
talloids during and immediately after several types of anesthe-
sia (epidural, spinal, isoﬂurane, and propofol) [50–53] and
surgery (thyroid, gall-bladder, and colon) [53–55] due to acti-
vation of stress hormones prompting ﬂuid retention. In all
such conditions, ﬂuid elimination would be much slower dur-
ing and immediately after the actual anesthetic or surgical pro-
cedures. In a RCT, although there was non-signiﬁcant
differences in 60 days morbidity, a neutral ﬂuid balance was
associated with improved lung function and shortened dura-
tion of mechanical ventilation [56]. Earlier studies and earlier
clinical guidelines suggested beneﬁts associated with a net even
approach to ﬂuid therapy [57].
It is clear through some studies that the ‘‘adequate’’ ﬂuid
therapy by ‘‘substitution’’ is of value, rather than the ‘‘liberal’’
or the ‘‘restrictive’’ approach [46,56,57]. It may be also clear
through the SAFE study that patient outcome is similar after
administration of either albumin 4% or saline [38]. It may beclear again that surgery – per se, or anesthesia – per se may
have a ﬁnger-print on patient outcome, rather than the vol-
umes or types of administered ﬂuids.
7. Hemoglobin therapy: too much or too little
Blood transfusion is a commonly performed medical proce-
dure in hospitalized patients. However, this life-saving strategy
is not without risks including transfusion-transmitted infec-
tions and immunomodulating effects that may increase the risk
of nosocomial infections and possibly the development of
autoimmune diseases later in life [58].
The conventional ‘‘transfusion trigger’’ of a hemoglobin
(Hb) level of 10 g/dl and hematocrit (Hct) of 30% has been re-
cently challenged. The minimum tolerable level of Hb is not
well-established, and considerable variations exist in transfu-
sion practice.
Patients with acute anemia in the preoperative period or if
critically-ill, have been shown to need blood transfusion with
Hb < 6 g/dl and not to need blood transfusion with Hb >
10 g/dl [59].
Packed red blood cells (PRBCs) are used to increase the Hb
concentration and improve the oxygen carrying capacity of the
blood. A unit of PRBCs of 250–300 ml and Hct of 60–80% in-
creases the Hb level by 1 g/dl and the Hct by 3–4% in an aver-
age sized adult. Clinical factors needed to perform blood
transfusion include the cause of anemia, its severity and acuity,
and the patient ability to compensate. Transfusion is not rou-
tinely needed in patients with chronic anemia or cancer unless
it is expected to improve their exercise ﬁtness.
Limited data are available on patient outcome with transfu-
sion therapy regarding a ‘‘liberal’’ or a ‘‘restrictive’’ approach.
A systematic review including 10 RCTs compared out-
comes with a ‘‘liberal’’ (transfusion trigger of 9–10 g/dl Hb)
versus a ‘‘restrictive’’ (transfusion trigger of 7–9 g/dl Hb) pre-
operative transfusion strategy [60]. Another meta-analysis of
35 RCTs, observational and experimental studies identiﬁed
‘‘liberal’’ and ‘‘restrictive’’ approaches of 10–12 g/dl and 7–
9 g/dl, respectively [61]. In both situations, the ‘‘liberal’’ ap-
proach was associated with increased adverse clinical outcome,
while the ‘‘restrictive’’ approach was associated with decreased
adverse clinical outcome including lower morbidity and mor-
tality (M/M) and shorter length of hospital stay. They support
the use of the ‘‘restrictive’’ strategy in patients free of serious
cardiac diseases, although an increased incidence of complica-
tions was reported at very low Hb levels, in agreement with
other studies [62,63].
The Transfusion Requirements In Critical Care (TRICC)
investigators found that a ‘‘restrictive’’ approach was associ-
ated with lower morbidity in critically-ill patients, with the
conclusion that the ‘‘restrictive’’ approach is as effective or
even superior to the ‘‘liberal’’ one [64]. Other authorities
showed that Hb ‘‘transfusion trigger’’ of 7 g/dl had no negative
impact on M/M, either in the general ICU patients or in pa-
tients with coexisting cardiac diseases [64,65]. In patients with
coexisting cardiac disease, however, higher postoperative Hb
trigger of 8 g/dl was justiﬁed, given the likelihood of postoper-
ative tachycardia and compromised oxygenation [59].
Perioperative blood transfusion therapy in hospitalized pa-
tients could be withheld as long as a patients Hb level remained
at 7 g/dl or higher, and the patient was not actively bleeding [60].
On the other hand, patients with cardiac diseases might need to
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gen carrying capacity and to improve their quality of life [60].
8. Conclusions
It may be concluded that an ‘‘adequate’’ rather than a ‘‘liber-
al’’ or a ‘‘restrictive’’ perioperative ﬂuid approach may
represent the gateway to improved patient outcome. An ‘‘ade-
quate’’ approach implies a careful ‘‘substitution’’ of ﬂuid def-
icits, losses, and needs, because the body normally strives to
maintain its volume homeostasis.
Blood should be transfused for all patients with Hb < 6 g
/dl and not to be transfused for any patient with Hb > 10 g/
dl. Transfusion of blood may be withheld as long as a patient’s
Hb remains at 7 g/dl or higher, and he is not actively bleeding.
A blood ‘‘transfusion trigger’’ may be 9–10 g/dl for a patient
with cardiac disease to raise his oxygen carrying capacity. Fur-
ther systematic reviews of RCTs are needed for evidence-based
perioperative ﬂuid regimens, including Hb therapy.
9. Key-points
– After the ongoing controversy on colloids versus crystal-
loids, the main focus is now on the amount of applied ﬂuids
in general.
– Perioperative blood volume is normal (after replacement of
blood loss), because losses following fasting, urine forma-
tion, and insensible perispiration are negligible, and a
third-space is non-existent.
– A distinction should be made between type 1 (physiologic)
and type 2 (pathologic) ﬂuid shifting, that should be treated
accordingly. Crystalloids physiologically load the intersti-
tial space. Colloid loading may induce hypervolemia with
destruction of glycocalyx, a vital part of the biological
membrane.
– A successful plan should address the right kind of ﬂuids, in
appropriate amounts, at the right time to reduce the endo-
thelial barrier damage.
– An ‘‘adequate’’ or ‘‘substitution’’ rather than a ‘‘liberal’’ or
a ‘‘restrictive’’ ﬂuid approach might be the proper gateway
to improve patient outcome.
– Blood transfusion should be withheld in patients with non-
cardiac diseases and who are not actively bleeding, so long
as their Hb is 7 g/dl or higher. Patients with cardiac diseases
need a ‘‘transfusion trigger’’ of 9–10 g/dl to raise their oxy-
gen carrying capacity.
– Further systematic reviews of RCTs are needed to formu-
late evidence-based guidelines for perioperative ﬂuid
management.Acknowledgment
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